Cargando…
Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. METHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 ou...
Autores principales: | Lee, Vernon J, Yap, Jonathan, Tay, Joshua K, Barr, Ian, Gao, Qiuhan, Ho, Hanley J, Tan, Boon Huan, Kelly, Paul M, Tambyah, Paul A, Kelso, Anne, Chen, Mark I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901357/ https://www.ncbi.nlm.nih.gov/pubmed/20537158 http://dx.doi.org/10.1186/1471-2334-10-164 |
Ejemplares similares
-
Effectiveness of Pandemic H1N1-2009 Vaccination in Reducing Laboratory Confirmed Influenza Infections among Military Recruits in Tropical Singapore
por: Lee, Vernon J., et al.
Publicado: (2011) -
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
por: Reddy, David
Publicado: (2010) -
Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009
por: Lim, Wei-Yen, et al.
Publicado: (2011) -
Risk Factors for Pandemic (H1N1) 2009 Virus Seroconversion among Hospital Staff, Singapore
por: Chen, Mark I.C., et al.
Publicado: (2010) -
Molecular Evidence of Transmission of Influenza A/H1N1 2009 on a University Campus
por: Virk, Ramandeep Kaur, et al.
Publicado: (2017)